ClinicalTrials.gg
CompletedNCT06963996Updated Sep 3, 2025

Efficacy of a Psychoeducational Intervention to Improve Sleep Health Among University Students

An interventional study of Sleep health education in Psychoeducational and Psychoeducational Waitlist Control, sponsored by Laval University. Completed at 1 site in Canada. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-03.

Sponsored by Laval University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Feb 2024, registered Mar 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
92
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

This study aims to evaluate the efficacy of a psychoeducational intervention targeting the determinants of university students' sleep health. It is conducted as part of a doctoral research project.

The intervention consists of three structured sessions delivered over three weeks, with additional online follow-ups. Each session lasts 1.5 hours and takes place in the evening, with a one-week interval between sessions.

Session 1 focuses on providing fundamental knowledge about sleep health. Session 2 introduces behavioral strategies to improve sleep health and asks participants to implement behavior change intentions.

Session 3 reviews the implementation of the intention, the changes made or not, and addresses the relationship between stress and sleep, along with coping strategies.

Participants are required to complete online questionnaires and a sleep diary at multiple time points: before the intervention, immediately after, and up to three months post-intervention. These assessments measure sleep habits, beliefs about sleep, and mental health indicators.

Participants are randomly assigned to one of two groups:

Intervention group, which receives the psychoeducational program first. Waitlist control group, which completes an additional follow-up before receiving the intervention.

The study design allows for a controlled evaluation of the intervention's impact on sleep-related behaviors and mental health outcomes.

Read the detailed description

A process evaluation will be conducted immediately after the 3 weeks intervention to assess participants' comprehension, adherence to the intervention, as well as the accessibility and relevance of intervention content. Moreover, in terms of logistics, this involves evaluating the premises used, the facilitator, the size of the group, the number and length of sessions, the face-to-face offer, and the use of teaching aids such as manuals during the sessions. These data are collected to inform potential improvements in future iterations of the intervention and are not included as outcome measures.

02

Conditions studied

  • Psychoeducational
  • Psychoeducational Waitlist Control

Keywords

  • psychoeducation
  • sleep
  • sleep hygiene
  • randomized controlled trial
  • waiting lists
  • control groups
  • sleep health
  • health education
  • intention
  • behavioral intention
  • health behavior
  • self-management
03

In context

Sleep Hygiene

126 studies on the registry are indexed under Sleep Hygiene; 32 are open to participants now.

This study's enrollment of 92 is above the median of 66 across 113 interventional studies indexed under Sleep Hygiene.

Browse Sleep Hygiene studies →

Lead sponsor

Laval University is the lead sponsor of 380 studies on the registry; 67 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Students registered at Université Laval (either part-time or full-time)
  • Aged between 18-30 years old
  • With or without any sleep difficulties

Exclusion criteria

Exclusion Criteria:

  • Use of prescription sleep medication
  • Diagnosed medical condition (diabetes, cancer, cardiovascular disease, chronic pain, etc.)
  • Currently with a suicidal risk
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
92 participants (actual)

Study arms

  • Experimental
    Intervention group

    Participants assigned to the intervention group will receive first the intervention. They will complete various assessment at baseline (T0), post-intervention after the 3 weeks of intervention (T1), and 3 months after the end of the intervention (T2).

    Behavioral: Sleep health education

  • Experimental
    Waitlist control group

    Participants assigned to the waitlist control group complete a baseline assessment (T0), a second assessment after 3 weeks of waiting (T1), and then receive the intervention. They are assessed again after the intervention (T2) and at 3-month follow-up (T3). This design allows for pre- and post-intervention comparisons while ensuring delayed access to the program.

    Behavioral: Sleep health education

Interventions

  • BehavioralSleep health education

    The intervention consists of three structured sessions delivered over three weeks, with additional online follow-ups. Each session lasts 1.5 hours and takes place in the evening, with a one-week interval between sessions. Session 1 focuses on providing fundamental knowledge about sleep health. Session 2 introduces behavioral strategies to improve sleep health and asks participants to implement behavior change intentions. Session 3 reviews the implementation of the intention, the changes made or not, and addresses the relationship between stress and sleep, along with coping strategies.

06

What researchers measure

Primary outcomes

  1. RU-SATED

    RU-SATED is the instrument used to measure sleep health. Sleep health varies according to individual, social and environmental conditions, and emphasises that good sleep is not simply the result of an absence of sleep disorders. In terms of its components, sleep health relates to (1) sleep duration, or the total number of hours of sleep obtained over 24 hours, (2) sleep efficiency, corresponding to the ease or otherwise with which an individual falls asleep and returns to sleep, and (3) timing, or how our sleep fits into a 24-hour day, (4) alertness, or sleepiness, which concerns a person's ability to maintain a state of attentive wakefulness throughout the day, (5) satisfaction, or subjectively represented sleep quality, and finally (6) sleep regularity. More specifically, RU-SATED score is distributed between 0 and 12, with the higher the score, the better the person's sleep health.

    Time frame: Intervention group: T0 (day 1), T1 week 4 (post 3 weeks intervention), T2 week 16 (3 months post-intervention). Waitlist control group: T0 (day 1), T1 (3 weeks later T0), T2 week 8 (post 3 weeks intervention), T3 week 20 (3 months post-intervention).

  2. Sleep satisfaction

    Sleep satisfaction will be assessed using a single-item question from a sleep diary completed by participants each morning for seven consecutive days. The item reads: "How would you rate the quality of your sleep?" Responses are recorded on a 5-point Likert scale ranging from 1 ("very restless") to 5 ("Very deep"). Daily scores will be summed to obtain a total sleep satisfaction score ranging from 7 to 35. Higher scores indicate a higher perceived sleep quality. The measure provides a subjective evaluation of sleep quality from the participant's perspective.

    Time frame: 1-week daily self-reports at each time point: T0 (day 1), T1 week 4 (post 3-week intervention), T2 week 16 (3-month follow-up); waitlist group: T0, T1 (3 weeks later), T2 week 8 (post 3-week intervention), T3 week 20 (3-month follow-up).

  3. Sleep timing

    Self-reported bedtime and wake-up time recorded daily in a sleep diary. Used to calculate the timing of sleep onset and wake time, as well as midpoint of sleep.

    Time frame: 1-week daily self-reports at each time point: T0 (day 1), T1 week 4 (post 3-week intervention), T2 week 16 (3-month follow-up); waitlist group: T0, T1 (3 weeks later), T2 week 8 (post 3-week intervention), T3 week 20 (3-month follow-up).

  4. Sleep efficiency

    Calculated from self-reported sleep diary entries as the ratio of total sleep time to time in bed, expressed as a percentage.

    Time frame: 1-week daily self-reports at each time point: T0 (day 1), T1 week 4 (post 3-week intervention), T2 week 16 (3-month follow-up); waitlist group: T0, T1 (3 weeks later), T2 week 8 (post 3-week intervention), T3 week 20 (3-month follow-up).

  5. Sleep duration

    Self-reported total sleep time calculated daily using sleep onset and wake-up time entries in the sleep diary.

    Time frame: 1-week daily self-reports at each time point: T0 (day 1), T1 week 4 (post 3-week intervention), T2 week 16 (3-month follow-up); waitlist group: T0, T1 (3 weeks later), T2 week 8 (post 3-week intervention), T3 week 20 (3-month follow-up).

  6. Sleep regularity

    Measured via self-reported bedtimes and wake-up times across multiple days using a sleep diary. Variability will be calculated using the standard deviation of sleep and wake times to assess sleep regularity.

    Time frame: 1-week daily self-reports at each time point: T0 (day 1), T1 week 4 (post 3-week intervention), T2 week 16 (3-month follow-up); waitlist group: T0, T1 (3 weeks later), T2 week 8 (post 3-week intervention), T3 week 20 (3-month follow-up).

Secondary outcomes

  1. Sleep hygiene beliefs

    This outcome is assessed students' beliefs about sleep hygiene using the Theory of Planned Behavior (TPB). Since no standardized tools exist, items were developed based on prior research and theoretical guidelines. Validity was confirmed through factor analysis and internal consistency testing. The instrument includes 7-point Likert scales measuring: Attitudes (6 items) - Perceptions of sleep hygiene. Higher scores indicate more favorable attitudes (score range of 6 to 42). Subjective norms (4 items) - Perceived social expectations. Higher scores reflect stronger norms (score range of 4 to 28). Motivation to comply (4 items) - Importance given to others' opinions (score range of 4 to 28). Perceived control (4 items) - Confidence in maintaining good sleep habits (score range of 4 to 28). Intention (3 items) - Readiness to adopt healthy sleep behaviors (score range of 3 to 21). This structured approach ensures a comprehensive assessment of beliefs and behavioral influences.

    Time frame: Intervention group: T0 (day 1), T1 week 4 (post 3 weeks intervention), T2 week 16 (3 months post-intervention). Waitlist control group: T0 (day 1), T1 (3 weeks later T0), T2 week 8 (post 3 weeks intervention), T3 week 20 (3 months post-intervention).

  2. Sleep Hygiene Practice Scale

    Sleep hygiene is measured by the Sleep hygiene practice scale (SHPS), which is an instrument that measures sleep hygiene including 4 domains: (1) factors related to the sleep-wake cycle (e.g. irregular bedtime/rising time, lack of exposure to outside light), (2) factors related to activation and activating behaviours (e.g. falling asleep watching television or listening to music, intense exercise in the 2 hours before going to sleep), (3) factors related to consumption and diet (e.g.going to bed hungry, drinking alcohol close to bedtime), and (4) factors related to the sleep environment (e.g. sleeping environment too noisy, too bright, too hot). The total score is distributed between 30 and 180, where the higher the score, the higher the frequency of poor sleep hygiene practices.

    Time frame: Intervention group: T0 (day 1), T1 week 4 (post 3 weeks intervention), T2 week 16 (3 months post-intervention). Waitlist control group: T0 (day 1), T1 (3 weeks later T0), T2 week 8 (post 3 weeks intervention), T3 week 20 (3 months post-intervention).

  3. Self-efficacy

    This study evaluates self-efficacy in adopting, maintaining, and recovering sleep habits. Inspired by prior research, the instrument includes: Adoption efficacy (2 items) - Confidence in changing sleep habits despite difficulties. Maintenance efficacy (4 items) - Ability to sustain new sleep routines over time. Recovery efficacy (3 items) - Capacity to resume habits after interruption. Each item is rated on a 4-point Likert scale (1 = "Completely false," 4 = "Completely true"). The range of scores is 2 to 8, 4 to 16 and 3 to 12 respectively. Higher scores indicate stronger self-efficacy in each domain.

    Time frame: Intervention group: T0 (day 1), T1 week 4 (post 3 weeks intervention), T2 week 16 (3 months post-intervention). Waitlist control group: T0 (day 1), T1 (3 weeks later T0), T2 week 8 (post 3 weeks intervention), T3 week 20 (3 months post-intervention).

Other outcomes

  1. Perceived stress

    Perceived stress is evaluated using the Perceived Stress Scale (PSS), which measures how stressful life situations are perceived. This self-administered questionnaire consists of 14 items, rated on a 5-point Likert scale (0 = "Never", 1 = "Almost never", 2 = "Sometimes", 3 = "Fairly often", 4 = "Very often"). The total score ranges from 0 to 56, with higher scores indicating greater perceived stress. The PSS will be used to control for stress levels during evaluation phases, especially around exam periods, when participants are expected to report higher stress levels.

    Time frame: Intervention group: T0 (day 1), T1 week 4 (post 3 weeks intervention), T2 week 16 (3 months post-intervention). Waitlist control group: T0 (day 1), T1 (3 weeks later T0), T2 week 8 (post 3 weeks intervention), T3 week 20 (3 months post-intervention).

  2. Anxiety

    Anxiety is evaluated using the GAD-7 (Generalized Anxiety Disorder scale). This 7-item self-report tool assesses anxiety symptoms experienced over the past two weeks, such as feeling nervous, unable to control worries, or having difficulty relaxing. Each item is scored from 0 to 3, indicating the frequency of symptoms. The total score ranges from 0 to 21, with thresholds at 5, 10, and 15 categorizing anxiety as mild, moderate, or severe. A score of 10 or higher is used to identify clinical levels of anxiety, which will be applied to distinguish students with clinically significant anxiety in this study.

    Time frame: Intervention group: T0 (day 1), T1 week 4 (post 3 weeks intervention), T2 week 16 (3 months post-intervention). Waitlist control group: T0 (day 1), T1 (3 weeks later T0), T2 week 8 (post 3 weeks intervention), T3 week 20 (3 months post-intervention).

  3. Depression

    The PHQ-9 will assess students' depression levels, with scores ≥10 indicating clinical depression. This self-administered questionnaire evaluates the presence and severity of depressive symptoms over the past two weeks. It consists of nine items rated on a four-point Likert scale (0 = "not at all" to 3 = "nearly every day"), resulting in a total score from 0 to 27. Severity thresholds are: minimal (1-4), mild (5-9), moderate (10-14), moderately severe (15-19), and severe (20-27).

    Time frame: Intervention group: T0 (day 1), T1 week 4 (post 3 weeks intervention), T2 week 16 (3 months post-intervention). Waitlist control group: T0 (day 1), T1 (3 weeks later T0), T2 week 8 (post 3 weeks intervention), T3 week 20 (3 months post-intervention).

  4. Insomnia Severity Index

    The Insomnia Severity Index (ISI) assesses nocturnal and daytime insomnia symptoms. It consists of seven items rated on a five-point Likert scale, with total scores ranging from 0 to 28. Clinical thresholds categorize scores as no insomnia (0-7), subclinical insomnia (8-14), moderate clinical insomnia (15-21), and severe clinical insomnia (22-28). The ISI is a validated and reliable tool (Cronbach's alpha = .74). This measure will be used to control for sleep health outcomes, distinguishing students with scores above 10, indicating probable insomnia.

    Time frame: Intervention group: T0 (day 1), T1 week 4 (post 3 weeks intervention), T2 week 16 (3 months post-intervention). Waitlist control group: T0 (day 1), T1 (3 weeks later T0), T2 week 8 (post 3 weeks intervention), T3 week 20 (3 months post-intervention).

  5. Sociodemographic measures

    Time frame: Day 1 (T0)

07

Study locations

1 site
  • Centre d'études des troubles du sommeil (CETS)
    Québec, Quebec G1V 0A6, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2024 to primary completion in Aug 2025, 18 months.

Of 75 non-industry interventional studies with no phase under Sleep Hygiene, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 18. This study's 18 months is above that.

Counting every sponsor, half of 79 studies reached it within 8 months; a quarter within 4 and three quarters within 18.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 18, 2025
First posted
May 9, 2025
StartActual
Feb 1, 2024
Primary completionActual
Aug 3, 2025
CompletionActual
Aug 3, 2025
Last update
Sep 3, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06963996
Lead sponsor
Laval University
Responsible party
Charles M. Morin (Professor, Laval University) — Principal investigator
First posted
May 9, 2025
Start date
Feb 1, 2024
Primary completion
Aug 3, 2025
Completion
Aug 3, 2025
Last update
Sep 3, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion